SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is currently seeing intense community debate as investors weigh the stock's defensive reputation against its recent price volatility and ongoing regulatory uncertainty. While some traders are focused on short-term technical setups and potential catalysts from upcoming CMS Medicare Advantage rate decisions, many are questioning if the stock is a value-buy opportunity or a long-term trap.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors grapple with legal uncertainty following court rulings regarding the addictive nature of its social media platforms. The community is sharply divided, with some investors viewing the decline as a major buying opportunity due to strong underlying cash flow and AI integration, while others fear long-term liability risks and regulatory headwinds that could fundamentally disrupt the company's business model.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing increased investor attention as a strengthened balance sheet from a completed pension reversion fuels optimism for its strategic pivot into pharmaceutical API manufacturing and advanced battery materials. The community is actively discussing potential government contracts for domestic drug supply chains and the possibility of a significant revaluation or corporate buyout, with many long-term shareholders holding firm for a breakout.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

The Vanguard S&P 500 ETF is seeing heightened trading volume and social media engagement as investors weigh the impact of geopolitical instability in the Middle East against the potential for a market rotation. Community discussions are split between bearish concerns regarding high valuations and broader macroeconomic uncertainty versus a disciplined 'buy the dip' sentiment among long-term investors.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is trending as the company issued a vigorous, data-backed rebuttal against a short-seller report, providing evidence to refute allegations of channel stuffing and business malpractice. Investors are actively debating the long-term outlook, with many expressing strong confidence in management's growth strategy and share buybacks while closely monitoring institutional support and the stock's volume.

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

The S&P 500 is experiencing heightened volatility as market participants weigh geopolitical instability in Iran against persistent hopes for a breakthrough in peace negotiations. Community sentiment is deeply divided, with many traders closely monitoring algorithmic price action and speculative headlines while debating whether to hedge positions ahead of the weekend.

Blacksky Technology, Inc. is a space-based intelligence company, which engages in the business of delivering real-time imagery, analytics, and high-frequency monitoring of most critical and strategic locations, economic assets, and events. The firm is also involved in providing geospatial intelligence, imagery and related data analytic products and services, and mission systems that include the development, integration, and operation of satellite and ground systems to government and commercial customers. The company was founded in 2014 and is headquartered in Herndon, VA.

BlackSky Technology Inc - Ordinary Shares - Class A

BlackSky Technology is experiencing significant volatility and a notable price correction as investors weigh the company's long-term potential in the satellite intelligence sector against frustration over launch delays and a lack of recent news catalysts. While some in the community see the recent pullback as a strategic entry point and remain bullish on the company's backlog and government contract pipeline, others are expressing concern over the lack of consistent operational progress and the stock's sensitivity to broader sector movements.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software shares are trending following reports that the company is considering a sale of its China division, an asset community members value for its deep integration into the region's mobile and EV software ecosystems. While the news has triggered speculation about a significant cash injection and potential debt relief, traders remain divided on whether this move signals a necessary strategic streamlining or a desperate attempt to shore up the balance sheet.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending as investors weigh strong earnings performance and consistent guidance raises against the broader volatility in the software sector. The community is actively debating the company's competitive position against legacy players like The Trade Desk, with many bulls pointing to recent AI product launches and institutional accumulation as primary catalysts for a potential rebound.

Monke, the Ethereum ape, trades with conviction and holds gems, striving to make it big and quit his 9-5 job.

Monke

The community is rallying behind MONKE as the project releases significant updates to its game, Monke Island, while highlighting the integration of staking rewards and NFT utilities to drive long-term engagement. Investors are expressing high conviction, viewing the project's consistent development and cult-like following as key indicators for future growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

All You Need to Know About Rapport Therapeutics, Inc. (RAPP) Rating Upgrade to Buy

Rapport Therapeutics, Inc. (RAPP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Baker BROS. Advisors LP Has $45.95 Million Position in Rapport Therapeutics, Inc. $RAPP

Baker BROS. Advisors LP grew its stake in shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP - Free Report) by 181.2% during the 3rd quarter, according to the company in its most recent filing with...

Rapport Therapeutics (NASDAQ:RAPP) Downgraded to "Sell" Rating by Wall Street Zen

Wall Street Zen lowered Rapport Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

Q1 EPS Estimate for Rapport Therapeutics Lifted by Analyst

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Free Report) - Research analysts at HC Wainwright raised their Q1 2026 earnings estimates for Rapport Therapeutics in a research note issued to investors on...

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 7.7% - Should You Sell?

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 7.7% - Here's What Happened...

Equities Analysts Offer Predictions for RAPP FY2030 Earnings

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Free Report) - Equities researchers at HC Wainwright issued their FY2030 earnings per share (EPS) estimates for Rapport Therapeutics in a research report...

Rapport Therapeutics (NASDAQ:RAPP) Price Target Raised to $46.00 at Wells Fargo & Company

Wells Fargo & Company upped their target price on Rapport Therapeutics from $43.00 to $46.00 and gave the company an "overweight" rating in a report on Wednesday...

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down on Disappointing Earnings

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down Following Weak Earnings...

Cheryl Gault Sells 2,014 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock

Rapport Therapeutics, Inc. (NASDAQ:RAPP - Get Free Report) COO Cheryl Gault sold 2,014 shares of the firm's stock in a transaction that occurred on Thursday, March 5th. The stock was sold at an...

Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Tuesday

Rapport Therapeutics (NASDAQ:RAPP) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 10. (View Earnings Report at...

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.61	--	--	N/A
Q4 '25	-$0.68	-$0.72	-6.28%	MISSED
Q3 '25	-$0.78	-$0.71	8.39%	BEAT
Q2 '25	-$0.81	-$0.75	7.89%	BEAT
Q1 '25	-$0.76	-$0.68	10.53%	BEAT

RAPP
Rapport Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest Earnings Results: Q4 '25

Historical Earnings

Latest RAPP News

RAPPRapport Therapeutics Inc